MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Advanced-stage ovarian cancer patients with BRCA live longe

Back to research news Blogs list Cancer blog  


Subscribe To Research News RSS Feed  RSS content feed What is RSS feed?

Advanced-stage ovarian cancer patients with BRCA live longe




Advanced-stage ovarian cancer patients with BRCA live longe
Two abstracts underscoring the importance of testing for BRCA1/2 mutations in women with ovary cancer were presented at this week's Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancers, by scientists from The University of Texas M. D. Anderson Cancer Center.


Advanced-stage ovarian cancer patients with BRCA live longe

In the first study, a multicenter research team led by M.D. Anderson found advanced- stage ovary cancer patients with non-Ashkenazi Jewish BRCA (non-AJ BRCA) mutations experience longer progression-free and overall survival rates in comparison to those with sporadic ovary cancer. The data confirms prior research which reported that among ovary cancer patients of Ashkenazi-Jewish heritage, BRCA1/2 mutations (AJ BRCA) are associated improved long-term survival.

For this study, scientists examined 85 advanced-stage ovary cancer patients with non-AJ BRCA mutations and 116 patients who did not express any type of BRCA mutation. In comparison to patients without BRCA mutations, non-AJ BRCA carriers had longer progression-free survival of 19.0 vs. 27.8 months and improved overall survival of 65.6 vs. 101.4 months. Non-AJ BRCA patients had a 2.15 times greater odds of complete response to initial chemotherapy response over sporadic, non-carrier patients.

Karen Lu, M.D., associate professor in the Department of Gynecologic Oncology at M. D. Anderson and senior author on the study said the difference in survival rates indicate that individuals with BRCA mutations might respond better to standard chemotherapy for ovary cancer. "Thus, it becomes increasingly valuable to know a patient's BRCA status to guide and personalize therapy decisions," Lu said.

Majority of Patients Unaware BRCA Testing Available
A second study conducted at M. D. Anderson concluded that, despite being available for more than 10 years, a majority of women with ovary cancer were unaware genetic counseling and testing for BRCA1/2 mutations was an option. Of the 225 ovary cancer patients surveyed, 56 percent had not heard of BRCA testing. This lack of awareness was more profound in minorities - 69 percent of Hispanic and 88 percent of African American respondents were unaware of BRCA testing in comparison to 52 percent of white women.

"Patients typically associate genetic testing with benefiting family members and offspring," Lu said. "Both of these studies illustrate that it is equally important for the cancer patient to get information from their doctors about genetic testing because it not only has implications for their family, but their own therapy and prognosis."

She said that more than 85 percent of ovary cancer patients surveyed would be willing to undergo BRCA testing if it would affect their care, but the cost of testing may be a barrier. "Currently, oncologists are inconsistent in their testing for BRCA mutations. Based on the therapy implications of our findings and the surprisingly low knowledge that such testing is available, we recommend developing ways to systematically evaluate every ovary cancer patient for BRCA," Lu said.

A family history of breast and/or ovary cancer is reported in approximately five percent to 15 percent of ovary cancer cases, with BRCA1/2 mutations expressed in a significant proportion of these cases.


Posted by: Scott    Source




Did you know?
Two abstracts underscoring the importance of testing for BRCA1/2 mutations in women with ovary cancer were presented at this week's Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancers, by scientists from The University of Texas M. D. Anderson Cancer Center.

Medicineworld.org: Advanced-stage ovarian cancer patients with BRCA live longe

Acute bacterial meningitis| Alzheimer's disease| Carpal tunnel syndrome| Cerebral aneurysms| Cerebral palsy| Chronic fatigue syndrome| Cluster headache| Dementia| Epilepsy seizure disorders| Febrile seizures| Guillain barre syndrome| Head injury| Hydrocephalus| Neurology| Insomnia| Low backache| Mental retardation| Migraine headaches| Multiple sclerosis| Myasthenia gravis| Neurological manifestations of aids| Parkinsonism parkinson's disease| Personality disorders| Sleep disorders insomnia| Syncope| Trigeminal neuralgia| Vertigo|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.